Publication:
Sleep quality impairments in schizophrenia and bipolar affective disorder patients continue during periods of remission: a case-controlled study

dc.contributor.coauthorHacımusalar, Yunus
dc.contributor.coauthorKaraaslan, Özgül
dc.contributor.coauthorMısır, Emre
dc.contributor.coauthorHacımusalar, Göknur
dc.contributor.departmentN/A
dc.contributor.kuauthorAmuk Williams, Özge Ceren
dc.contributor.kuprofileUndergraduate Student
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.contributor.yokidN/A
dc.date.accessioned2024-11-10T00:02:09Z
dc.date.issued2022
dc.description.abstractObjective: Bipolar disorder (BD) and schizophrenia are chronic psychiatric disorders in which sleep disorders are commonly seen. In mental disorders, residual symptoms may persist even if symptoms are greatly reduced overall. The aim of this study was to compare the sleep quality of schizophrenia and BD patients in remission with that of healthy controls. Methods: Forty-three patients with schizophrenia, 46 BD patients in remission for at least 3 months, and 51 healthy controls were included the study. The Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Young Mania Rating Scale (YMRS) and Pittsburgh Sleep Quality Index (PSQI) were administered to all participants and the Positive and Negative Syndrome Scale (PANSS) was administered to patients with schizophrenia. Results: Poor sleep quality was more frequent in the patient groups than the control group (p=0.009). PSQI score was positively correlated with duration of disease (r=0.236; p=0.026), number of cigarettes smoked per day (r=0.430; p<0.001), body mass index (r=0.189; p=0.025), and negatively correlated with duration of remission (r=-0.224; p=0.0359). Conclusion: Schizophrenia and BD patients in remission had worse sleep quality than a control group. Sleep quality was worst in the patients with schizophrenia. The severity of sleep disorder symptoms was positively associated with disease duration and negatively associated with duration of remission. Schizophrenia and BD patients should be carefully evaluated for symptoms of sleep disorders even when they are in clinical remission and should be offered additional treatment for sleep disorder symptoms when necessary.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue1
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.volume15
dc.identifier.doi10.5935/1984-0063.20210036
dc.identifier.eissn1984-0063
dc.identifier.issn1984-0659
dc.identifier.scopus2-s2.0-85132760112
dc.identifier.urihttp://dx.doi.org/10.5935/1984-0063.20210036
dc.identifier.urihttps://hdl.handle.net/20.500.14288/16069
dc.identifier.wos797563100007
dc.keywordsBipolar Disorder
dc.keywordsSchizophrenia
dc.keywordsSleep
dc.keywordsSleep disorders
dc.keywordsCircadian rhythm disturbance
dc.keywordsScale
dc.keywordsRisk
dc.keywordsMetaanalysis
dc.keywordsIndividuals
dc.keywordsReliability
dc.keywordsInventory
dc.keywordsValidity
dc.keywordsIndex
dc.keywordsDrugs
dc.languageEnglish
dc.publisherBrazilian Assoc Sleep
dc.sourceSleep Science
dc.subjectClinical neurology
dc.titleSleep quality impairments in schizophrenia and bipolar affective disorder patients continue during periods of remission: a case-controlled study
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0002-1589-3193
local.contributor.kuauthorAmuk Williams, Özge Ceren

Files